Tuanjie Guo

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Amino acid metabolic reprogramming in clear cell renal cell carcinoma: Pathogenic mechanisms and therapeutic targeting.

Amino acid metabolic reprogramming in clear cell renal cell carcinoma: Pathogenic mechanisms and therapeutic targeting.

Journal: Cancer letters

Published: October 14, 2025

Late embryogenesis abundant protein 3-modified human umbilical cord mesenchymal stem cell sheet exhibits antifreeze properties.

Late embryogenesis abundant protein 3-modified human umbilical cord mesenchymal stem cell sheet exhibits antifreeze properties.

Journal: International journal of biological macromolecules

Published: May 28, 2025

Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors.

Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors.

Journal: Cell & bioscience

Published: December 01, 2024

Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma.

Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma.

Journal: Clinical and experimental medicine

Published: November 18, 2024

SCGN recruits macrophages by regulating chemokine secretion in clear cell renal cell carcinoma.

SCGN recruits macrophages by regulating chemokine secretion in clear cell renal cell carcinoma.

Journal: International journal of biological sciences

Published: September 04, 2024

ALK-positive large B-cell lymphoma: a clinicopathological and molecular characteristics analysis of seven cases.

ALK-positive large B-cell lymphoma: a clinicopathological and molecular characteristics analysis of seven cases.

Journal: Pathology

Published: March 20, 2024

Establishment and identification of bladder cancer cell sheet.

Establishment and identification of bladder cancer cell sheet.

Journal: Computational and structural biotechnology journal

Published: March 14, 2024

GXYLT2: an emerging therapeutic target and predictive biomarker for anti-PD-1 efficacy in clear cell renal cell carcinoma.

GXYLT2: an emerging therapeutic target and predictive biomarker for anti-PD-1 efficacy in clear cell renal cell carcinoma.

Journal: Genes and immunity

Published: January 28, 2024

Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images.

Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images.

Journal: Journal of translational medicine

Published: December 07, 2023

Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study.

Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study.

Journal: International journal of surgery (London, England)

Published: November 25, 2023

Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach.

Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach.

Journal: Life sciences

Published: September 28, 2023

Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progression.

Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progression.

Journal: Discover oncology

Published: September 18, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026